- Company Overview for ARDANT PHARMACEUTICALS LTD. (09126357)
- Filing history for ARDANT PHARMACEUTICALS LTD. (09126357)
- People for ARDANT PHARMACEUTICALS LTD. (09126357)
- Charges for ARDANT PHARMACEUTICALS LTD. (09126357)
- More for ARDANT PHARMACEUTICALS LTD. (09126357)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
27 Jan 2025 | AA | Total exemption full accounts made up to 31 March 2024 | |
16 Jan 2025 | PSC04 | Change of details for Mr James Anthony Aylott as a person with significant control on 31 December 2024 | |
15 Jan 2025 | CS01 | Confirmation statement made on 15 January 2025 with updates | |
15 Jan 2025 | CH01 | Director's details changed for Mr James Anthony Aylott on 31 December 2024 | |
19 Dec 2024 | PSC04 | Change of details for Mr James Anthony Aylott as a person with significant control on 12 December 2024 | |
19 Dec 2024 | PSC07 | Cessation of Abri Coetzee as a person with significant control on 12 December 2024 | |
16 Oct 2024 | AD01 | Registered office address changed from 13 Montpelier Avenue Bexley DA5 3AP England to Unit 1 Unit 1 Vanguard Industrial Estate Henwood Ashford TN24 8DH on 16 October 2024 | |
15 Oct 2024 | TM01 | Termination of appointment of Ganesh Bhat Haregodu Ramakrishna as a director on 15 October 2024 | |
15 Oct 2024 | TM01 | Termination of appointment of Rajesh Chakraborty as a director on 15 October 2024 | |
13 Oct 2024 | PSC07 | Cessation of Pharmapro Healthcare Ltd as a person with significant control on 11 October 2024 | |
13 Oct 2024 | PSC01 | Notification of Abri Coetzee as a person with significant control on 11 October 2024 | |
13 Oct 2024 | PSC01 | Notification of James Anthony Aylott as a person with significant control on 11 October 2024 | |
08 Oct 2024 | AD01 | Registered office address changed from Unit 1 Vanguard Industrial Estate Henwood Ashford TN24 8DH England to 13 Montpelier Avenue Bexley DA5 3AP on 8 October 2024 | |
08 Oct 2024 | AD01 | Registered office address changed from 13 Montpelier Avenue Bexley DA5 3AP England to Unit 1 Vanguard Industrial Estate Henwood Ashford TN24 8DH on 8 October 2024 | |
08 Oct 2024 | CS01 | Confirmation statement made on 8 October 2024 with updates | |
08 Oct 2024 | AP01 | Appointment of Mr Rajesh Chakraborty as a director on 19 September 2024 | |
08 Oct 2024 | AP01 | Appointment of Mr Ganesh Bhat Haregodu Ramakrishna as a director on 19 September 2024 | |
08 Oct 2024 | PSC02 | Notification of Pharmapro Healthcare Ltd as a person with significant control on 8 September 2023 | |
08 Oct 2024 | PSC07 | Cessation of Abri Coetzee as a person with significant control on 17 September 2023 | |
08 Oct 2024 | PSC07 | Cessation of James Anthony Aylott as a person with significant control on 17 September 2023 | |
08 Oct 2024 | AD01 | Registered office address changed from Unit 1 Vanguard Industrial Estate Henwood Ashford Kent TN24 8DH England to 13 Montpelier Avenue Bexley DA5 3AP on 8 October 2024 | |
04 Oct 2024 | RP04CS01 | Second filing of Confirmation Statement dated 21 March 2024 | |
02 Oct 2024 | PSC01 | Notification of Abri Coetzee as a person with significant control on 17 September 2023 | |
02 Oct 2024 | PSC01 | Notification of James Anthony Aylott as a person with significant control on 17 September 2023 | |
02 Oct 2024 | PSC07 | Cessation of Pharmapro Healthcare Ltd as a person with significant control on 17 September 2023 |